Skip to content

Effectiveness and safety of cyclophosphamide for older microscopic polyangiitis patients on induction therapy

Effectiveness and safety of cyclophosphamide for older microscopic polyangiitis patients on induction therapy - Effectiveness and safety of cyclophosphamide for older microscopic polyangiitis patients on induction therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000043514
Enrollment
35
Registered
2021-04-01
Start date
2021-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Microscopic polyangitis

Interventions

None listed

Sponsors

Department of Nephrology & Dialysis Kitano Hospital, Tazuke Kofukai Medical Research Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: MPA patients aged 70 years or older who were diagnosed and treated at the Department of Nephrology, Kitano Hospital from 2001 to 2016

Exclusion criteria

Exclusion criteria: Patients who did not wish to actively treat vasculitis with immunosuppressive drugs

Design outcomes

Primary

MeasureTime frame
All cause mortality and renal survival

Countries

Japan

Contacts

Public ContactTatsuo Tsukamoto

Kitano Hospital, Tazuke Kofukai Medical Research Institute Department of Nephrology & Dialysis

t-tsukamoto@kitano-hp.or.jp06-63121-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026